Sanofi Q1 2013 - Interview with CFO Jérôme Contamine
PARIS -- May 2, 2013
Sanofi, a global and diversified healthcare leader, reports earnings for the
first-quarter of 2013. Jérôme Contamine, Chief Financial Officer of Sanofi,
comments on results and outlook.
Click to watch the video: http://bit.ly/101e4XC
Topics covered in the interview include:
- Emerging Markets
- Rare Diseases
- Multiple Sclerosis
- R&D Pipeline
- Capital Allocation
Sanofi, a global and diversified healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients’ needs. Sanofi has core
strengths in the field of healthcare with seven growth platforms: diabetes
solutions, human vaccines, innovative drugs, rare diseases, consumer
healthcare, emerging markets and animal health. Sanofi is listed in Paris
(EURONEXT: SAN) and in New York (NYSE: SNY).
Company website: www.sanofi.com
Sébastien Martel, +33 1 53 77 45 45
+33 1 53 77 45 02
Press spacebar to pause and continue. Press esc to stop.